Estimation of Diagnosis and Treatment Costs of Non-Alcoholic Fatty Liver Disease: A Two-Year Observation
Mohammad Ebrahim Ghamarchehreh(Baqiyatallah University of Medical Sciences), Seyed Moayed Alavian(Middle East Liver Disease Center)
Cited by 25
Related Papers
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
|The Lancet. Gastroenterology & hepatology|2023|399
Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 3
|Journal of Viral Hepatitis|2015|159
Strategies to manage hepatitis C virus infection disease burden – volume 3
|Journal of Viral Hepatitis|2015|93
The present and future disease burden of hepatitis C virus infections with today's treatment paradigm – volume 3
|Journal of Viral Hepatitis|2015|77